Condition

Malaria

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 40 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials40

Recruiting1

Common interventions25

Lead sponsors shown15

Clinical trials

40 shown

OPTImizing Malaria And HIV Treatment in a Shifting Landscape in AfricaNCT06967519 · 2025-12-18

Diabetes, Metabolic Syndrome and Risk of Malaria in CameroonNCT06278181 · 2023-09-21

Assessment of Safety and Immunogenicity of R21/Matrix-M™ in African Children Living With HIVNCT05385510 · 2023-01-10

Baromètre Santé Adulte 2021-2022NCT05218304 · 2021-07-26

Optimizing Malaria Treatment for HIV-Malaria Co-infected IndividualsNCT04708496 · 2021-01-18

Improving Maternal heAlth by Reducing Malaria in African HIV WomenNCT03671109 · 2019-09-18

Study to Evaluate Safety, Immunogenicity and Efficacy of PfSPZ Vaccine in HIV Negative and HIV Positive Tanzanian AdultsNCT03420053 · 2018-02-07

Prevention of Malaria in HIV-uninfected Pregnant Women and InfantsNCT02793622 · 2016-09-01

Leiden University Medical Center Mini Donor BankNCT02810613 · 2016-05-31

A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ PatientsNCT02527005 · 2015-09-01

Dolutegravir Interactions With Artemisinin-based Combination TherapiesNCT02242799 · 2015-06-01

Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2)NCT02282293 · 2014-12-09

Reducing the Burden of Malaria in HIV-uninfected Pregnant Women and InfantsNCT02163447 · 2014-06-23

Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western KenyaNCT01810731 · 2014-04-01

Impact of TMP-SMX Prophylaxis on Malaria Infection and Immunity in Children in UgandaNCT02094508 · 2014-03-07

Clinical Performance Evaluation of Fyodor Urine Malaria Test (UMT)NCT01921413 · 2013-07-01

Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)NCT01766830 · 2013-01-01

Antimalarial Pharmacology in Children and Pregnant Women in UgandaNCT01717885 · 2012-08-01

Pharmacology of Antimalarial Therapy With or Without Antiretroviral TherapyNCT01728961 · 2012-02-01

Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in KenyaNCT01425073 · 2012-02-01

Correlating Protection Against Malaria With Serum Profiles Against Plasmodium Falciparum Antigen RepertoiresNCT01214876 · 2010-08-01

Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and ChildrenNCT01148459 · 2010-07-30

Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant WomenNCT00993031 · 2009-12-15

Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in KenyaNCT00914225 · 2009-09-01

HIV Protease Inhibitors for the Prevention of Malaria in Ugandan ChildrenNCT00978068 · 2009-09-01

Evaluation of Alternative Antimalarial Drugs for Malaria in PregnancyNCT00811421 · 2009-09-01

Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAARTNCT00719602 · 2009-08-01

Study of DDT and Loss of Clinically-Recognized Pregnancies in South AfricaNCT00878098 · 2009-06-01

Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected AdultsNCT00869700 · 2009-06-01

The Sero-Prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon IslandsNCT01080989 · 2009-03-01

Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected AdultsNCT00790881 · 2008-10-01

The Effect of Malaria on Disease Progression of HIV/AIDSNCT00499876 · 2007-10-01

Role of Nitric Oxide in MalariaNCT00527163 · 2007-09-04

Interactions Between HIV and Malaria in African ChildrenNCT00527800 · 2007-08-01

Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected PatientsNCT00421473 · 2007-03-01

Drug Interaction Study Between Antimalarial and Anti-HIV MedicationsNCT00266058 · 2005-12-01

Relationship Between HIV and Malaria in Ugandan ChildrenNCT00356824 · 2005-11-01

Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug CombinationsNCT00697892 · 2005-07-01

In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected AdultsNCT00144352 · 2002-09-01

Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate ResistanceNCT00137657 · 2002-02-01

Common interventions

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

artemether / lumefantrine5 lopinavir / ritonavir3 efavirenz2 lamivudine2 mefloquine2 zidovudine2 amodiaquine1 artesunate1 atovaquone / proguanil1 azithromycin1 nevirapine1 placebo1 placebo Oral Tablet1

Leading sponsors

University of California, San Francisco 7 Centers for Disease Control and Prevention 3 International Maternal Pediatric Adolescent AIDS Clinical Trials Group 2 National Institute of Allergy and Infectious Diseases (NIAID) 2 Radboud University Medical Center 2 University of Cape Town 2 University of Washington 2 Agence Sanitaire et Sociale de Nouvelle Calédonie 1 Barcelona Institute for Global Health 1 Fran Aweeka 1 Fyodor Biotechnologies Inc 1 GlaxoSmithKline 1 Grant Dorsey, M.D, Ph.D. 1 Hospital Clinic of Barcelona 1 Kaohsiung Medical University Chung-Ho Memorial Hospital 1

Trial status mix

COMPLETED34

WITHDRAWN2

RECRUITING1

SUSPENDED1

TERMINATED1

UNKNOWN1

Phase mix

PHASE39

PHASE48

NA6

PHASE16

EARLY_PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.